Buy Rating Affirmed for Centessa Pharmaceuticals Amid Promising ORX750 Prospects and Favorable Trial Results
TipRanksApr 12 01:38 ET
Analysts' Top Healthcare Picks: AstraZeneca (AZN), Centessa Pharmaceuticals (CNTA)
TipRanksApr 10 07:11 ET
Centessa Pharmaceuticals Analyst Ratings
BenzingaApr 1 12:24 ET
Analysts Offer Insights on Healthcare Companies: Actinium Pharmaceuticals (ATNM) and Centessa Pharmaceuticals (CNTA)
TipRanksApr 1 10:20 ET
Upgraded Buy Rating and Price Target for Centessa Pharmaceuticals on SerpinPC's Market Potential
TipRanksMar 6 23:17 ET
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Centessa Pharmaceuticals (CNTA) and G1 Therapeutics (GTHX)
TipRanksFeb 13 05:41 ET
Centessa Pharmaceuticals: Buy Rating Backed by Strong Pipeline and Positive Drug Data
TipRanksFeb 12 08:18 ET
Buy Rating Affirmed for Centessa Pharmaceuticals on Strong R&D Prospects and Market Potential
TipRanksFeb 1 00:06 ET
Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA) and Vertex Pharmaceuticals (VRTX)
TipRanksDec 4, 2023 07:31 ET
Analysts Offer Insights on Healthcare Companies: Centessa Pharmaceuticals (CNTA), Lantheus (LNTH) and Carisma Therapeutics (CARM)
TipRanksDec 1, 2023 08:40 ET
Jefferies Upgrades Centessa to Buy, Cites Upcoming Data for Narcolepsy Drug
Seeking AlphaNov 15, 2023 14:36 ET
Centessa Pharmaceuticals Analyst Ratings
BenzingaNov 15, 2023 06:19 ET
Centessa Pharmaceuticals' Growth Potential: Diversified Drug Pipeline and Market Opportunities – A Buy Rating Analysis
TipRanksNov 15, 2023 04:15 ET
Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8
BenzingaOct 26, 2023 05:07 ET
Centessa Pharmaceuticals Analyst Ratings
BenzingaOct 26, 2023 05:05 ET
Hold Rating for Centessa Pharmaceuticals: Potential of ORX750 and Considerations for Future Development
TipRanksOct 26, 2023 04:50 ET
Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Centessa Pharmaceuticals (CNTA)
TipRanksSep 25, 2023 07:10 ET
Analysts Conflicted on These Healthcare Names: NeuBase Therapeutics (NBSE) and Centessa Pharmaceuticals (CNTA)
TipRanksAug 16, 2023 07:20 ET
Goldman Sachs Maintains Neutral on Centessa Pharmaceuticals, Raises Price Target to $5
BenzingaAug 15, 2023 08:44 ET
Centessa Pharmaceuticals Analyst Ratings
BenzingaAug 15, 2023 08:43 ET
No Data
No Data